🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

53 results for “CUMBERLAND PHARMACEUTICALS INC” Clear

  1. Ifetroban, Oral Capsule

    CUMBERLAND PHARMACEUTICALS INC

    Aspirin Exacerbated Respiratory Disease (AERD)

    phase 2 small molecule completed

    1 trial

  2. N-Acetylcysteine (NAC)

    CUMBERLAND PHARMACEUTICALS INC

    Radiocontrast Nephropathy

    phase 2 small molecule completed

    1 trial

  3. Oral Ifetroban

    CUMBERLAND PHARMACEUTICALS INC

    Scleroderma, Diffuse

    phase 2 small molecule active

    1 trial

  4. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Infections, Gram-Positive Bacterial

    phase 2 small molecule completed

    2 trials

  5. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Gram-Positive Bacterial Infections

    phase 2 small molecule terminated

    2 trials

  6. conivaptan

    CUMBERLAND PHARMACEUTICALS INC

    Liver Cirrhosis

    phase 2 small molecule completed

    1 trial

  7. conivaptan

    CUMBERLAND PHARMACEUTICALS INC

    Chronic Heart Failure

    phase 2 small molecule completed

    1 trial

  8. ranibizumab

    CUMBERLAND PHARMACEUTICALS INC

    Retinal Vein Occlusion

    phase 2 small molecule completed

    1 trial

  9. Acetadote

    CUMBERLAND PHARMACEUTICALS INC

    Glioblastoma

    phase 1 small molecule active

    1 trial

  10. IVIb

    CUMBERLAND PHARMACEUTICALS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  11. Kristalose

    CUMBERLAND PHARMACEUTICALS INC

    Bowel Evacuant Prior to Colonoscopy

    phase 1 small molecule completed

    1 trial

  12. conivaptan hydrochloride

    CUMBERLAND PHARMACEUTICALS INC

    Kidney Diseases

    phase 1 small molecule completed

    1 trial

  13. conivaptan hydrochloride

    CUMBERLAND PHARMACEUTICALS INC

    Liver Disease

    phase 1 small molecule completed

    2 trials

  14. telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Kidney Diseases

    phase 1 small molecule completed

    1 trial

  15. Conivaptan

    CUMBERLAND PHARMACEUTICALS INC

    Hyponatremia

    approved small molecule completed

    4 trials

  16. IV Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Chronic Pelvic Pain

    approved small molecule active

    1 trial

  17. IV ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Arthroscopic Knee Surgery

    approved small molecule completed

    1 trial

  18. IV ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

  19. Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Ductus Arteriosus, Patent

    approved small molecule terminated

    1 trial

  20. Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

  21. Intravenous Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Obesity

    approved small molecule completed

    1 trial

  22. Intravenous Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Fever

    approved small molecule terminated

    1 trial

  23. Intravenous ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    3 trials

  24. Ofirmev

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources